Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors
Ono, Taihei, Igawa, Satoshi, Kurahayashi, Shintaro, Okuma, Yuriko, Sugimoto, Ai, Kusuhara, Seiichiro, Ozawa, Takahiro, Fukui, Tomoya, Sasaki, Jiichiro, Mitsufuji, Hisashi, Yokoba, Masanori, Kubota, MaJournal:
Investigational New Drugs
DOI:
10.1007/s10637-020-00919-0
Date:
March, 2020
File:
PDF, 586 KB
2020